[Biological properties of antineoplastic drugs linked with macromolecular vehicles].
D000418:Albumins / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004357:Drug Synergism; D005340:Fibrinogen / Q000008:administration & dosage; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D037102:Lectins; D008081:Liposomes / Q000008:administration & dosage; D046911:Macromolecular Substances; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D014677:Pharmaceutical Vehicles; D011107:Polylysine / Q000008:administration & dosage
D000418:Albumins; D000970:Antineoplastic Agents; D006728:Hormones; D007074:Immunoglobulin G; D037102:Lectins; D008081:Liposomes; D046911:Macromolecular Substances; D014677:Pharmaceutical Vehicles; D002699:Chlorambucil; D011107:Polylysine; D004317:Doxorubicin; D005340:Fibrinogen; D008727:Methotrexate; D003630:Daunorubicin
Biologiczne wáściwości leków przeciwnowotworowych sprzezonych z makromolekularnymi nośnikami.